Temozolomide

Suppliers

Names

[ CAS No. ]:
85622-93-1

[ Name ]:
Temozolomide

[Synonym ]:
Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-
Temodal
Temozolamide
3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
TZM
M&B 39831
TEMODAR
Temozolomide
MFCD00866492
temosolomide

Chemical & Physical Properties

[ Density]:
2.0±0.1 g/cm3

[ Boiling Point ]:
526.6±42.0 °C at 760 mmHg

[ Melting Point ]:
212°C dec.

[ Molecular Formula ]:
C6H6N6O2

[ Molecular Weight ]:
194.151

[ Flash Point ]:
272.3±27.9 °C

[ Exact Mass ]:
194.055222

[ PSA ]:
108.17000

[ LogP ]:
-1.32

[ Vapour Pressure ]:
0.0±1.4 mmHg at 25°C

[ Index of Refraction ]:
1.895

[ Storage condition ]:
2-8°C

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ5927050
CHEMICAL NAME :
Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-
CAS REGISTRY NUMBER :
85622-93-1
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C6-H6-N6-O2
MOLECULAR WEIGHT :
194.18

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
125 mg/kg
TOXIC EFFECTS :
Tumorigenic - active as anti-cancer agent

MUTATION DATA

TYPE OF TEST :
DNA damage
TEST SYSTEM :
Rodent - mouse Leukocyte
DOSE/DURATION :
100 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 47,4884,1987

Safety Information

[ Symbol ]:

GHS07, GHS08

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H302-H315-H319-H335-H350-H360

[ Precautionary Statements ]:
P201-P261-P305 + P351 + P338-P308 + P313

[ Personal Protective Equipment ]:
Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ Hazard Codes ]:
T: Toxic;Xi: Irritant;

[ Risk Phrases ]:
R45

[ Safety Phrases ]:
S24/25-S45-S36/37-S26-S53

[ RIDADR ]:
NONH for all modes of transport

[ RTECS ]:
NJ5927050

[ HS Code ]:
2933990090

Synthetic Route

Precursor & DownStream

Precursor

  • Methylisocyanate 1 x 500mg neat
  • 5-Diazoimidazole-4-carboxamide
  • 5-amino-1-(N-methylcarbamoyl)imidazole-4-carboxamide
  • 3-(hydroxymethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
  • methyl iodide
  • 5-Amino-1H-imidazole-4-carboxamide hydrochloride
  • 4-Nitrophenyl chloroformate
  • 5-diazoimidazole-4-carboxiamide

DownStream

  • Temozolomide-8-carboxylic acid

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.

Stem Cells 33(1) , 101-10, (2014)

Despite advances in standard therapies, the survival of glioblastoma multiforme (GBM) patients has not improved. Limitations to successful translation of new therapies include poor delivery of systemi...

Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect.

J. Neurooncol. 122(1) , 21-33, (2015)

The poor prognosis of patients with glioblastoma fuels the search for more effective therapeutic compounds. We previously hypothesised that the neuroleptic olanzapine may enhance antineoplastic effect...

A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib

Biochem. Pharmacol. 95 , 16-27, (2015)

Nitrobenzoxadiazoles exert antitumor effects against vemurafenib-resistant melanoma cells by sustained activation of different MAPK pathways.


More Articles


Related Compounds

  • Temozolomide-d3
  • Temozolomideacid
  • Temozolomide INT
  • cyanotemozolomide
  • TeMozoloMide Metabolite-MTIC
  • TeMozoloMide Related CoMpound A
  • 2-(Cyclohex-1-en-1-yl)-N-((5-methylthiophen-2-yl)methyl)ethan-1-amine
  • (3-Methylbutyl)[(5-methylthiophen-2-yl)methyl]amine
  • (2-Methylbutan-2-yl)[(5-methylthiophen-2-yl)methyl]amine
  • [(3-Bromophenyl)methyl](3-methoxypropyl)amine
  • [(3-Bromophenyl)methyl](3-methylbutyl)amine
  • [(3-Bromophenyl)methyl](2-methylbutan-2-YL)amine
  • [(4-Ethylphenyl)methyl](3-methoxypropyl)amine
  • [(4-Ethylphenyl)methyl](3-methylbutyl)amine
  • [(4-Ethylphenyl)methyl](2-methylbutan-2-YL)amine
  • [(3-Methoxyphenyl)methyl](3-methylbutyl)amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.